(1 - 14 von 15
)
Novartis International AG: Novartis Phase III study shows ACZ
www.finanznachrichten.de
Novartis International AG /
Novartis Phase III study shows ACZ885 helped substantially reduce steroid use in 45% of patients with serious form of childhood...
sortiert nach Relevanz / Datum